Medical Xpress

APRIL 19, 2023

The skin is an appealing route for drug delivery because it allows drugs to go directly to the site where they're needed, which could be useful for wound healing, pain relief, or other medical and cosmetic applications.

Cosmetics 91

Cosmetics Drug Delivery Drugs 91

pharmaphorum

JULY 27, 2021

Drug delivery specialist Aptar Group has agreed a deal to take a near two-thirds share in Voluntis, a French developer of digital therapeutics (DTx), with a view to taking full control of the company later this year. per share in the initial deal, which will give it a 64.6% stake in the company. stake in the company.

Drug Delivery 111

Drug Delivery Insulin Cosmetics Development 111

Roots Analysis

AUGUST 8, 2023

Furthermore, a wide variety of drugs and macromolecules, including DNA , proteins, and imaging agents, can be encapsulated in liposomal vesicles due to their unique ability to entrap both lipophilic and hydrophilic substances. The various therapeutic applications of liposomes in drug delivery have been highlighted in the figure.

Drug Delivery Systems 52

Drug Delivery Systems Drug Delivery Drugs In-Vivo 52

Roots Analysis

FEBRUARY 20, 2022

Over the last decade, one of the major challenges faced by pharmaceutical players across the globe is low drug solubility. As a matter of fact, recently many drug developers have initiated formulating novel therapeutic interventions that utilize nanoparticles as a major component ( nanomedicines ). Our Social Media Platform.

Contract Manufacturing 52

Contract Manufacturing Bioavailability Manufacturing Drug Delivery Systems 52

Delveinsight

SEPTEMBER 20, 2021

The condition is not life-threatening, however, is often wrongly presumed as purely a cosmetic problem leading to ignorance and delay in the treatment. Three major Topical treatments are currently on the market with two of them being approved as late as 2014 by the US FDA. Penlac (Valeant Pharmaceuticals, Inc.),

Marketing 74

Marketing Cosmetics Drug Delivery Clinical Development 74

The Pharma Data

NOVEMBER 4, 2020

Ltd (“Juyou”), a biotechnology company that develops and sells medical and cosmetic skincare products, for the commercialization and development of Pliaglis ® in mainland China (the “License Agreement”). million and US$1.8 million. . Juyou Bio-Technology Co.,

Licensing 40

Licensing Licensing Dermatology Production 40